Kate Broderick
Chief Tech/Sci/R&D Officer chez MARAVAI LIFESCIENCES HOLDINGS, INC.
Profil
Kate E.
Broderick is currently the Senior Vice President-Research & Development at TriLink BioTechnologies LLC and the Chief Innovation Officer at Maravai Lifesciences Holdings, Inc. She previously worked at Inovio Pharmaceuticals, Inc. as the Senior Vice President-Research & Development from 2007 to 2022.
Dr. Broderick holds a doctorate degree from the University of Glasgow.
Postes actifs de Kate Broderick
| Sociétés | Poste | Début |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
TriLink BioTechnologies LLC
 TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. The company was founded by Terry Beck and Richard Hogrefe in 1996 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Anciens postes connus de Kate Broderick
| Sociétés | Poste | Fin |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2022 |
Formation de Kate Broderick
| University of Glasgow | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. The company was founded by Terry Beck and Richard Hogrefe in 1996 and is headquartered in San Diego, CA. | Commercial Services |
